Measuring and Monitoring Patient Informed Clinical Outcomes In Psychological Therapy Supervision (MEMOS)

April 17, 2019 updated by: Professor Kate Davidson, NHS Greater Glasgow and Clyde

Measuring and Monitoring Patient Informed Clinical Outcomes In Psychological Therapy Supervision - A Stepped Wedge Cluster Randomised Controlled Trial

Providing feedback on patient progress to therapists improves clinical outcomes for patients, particularly those who are failing to improve with therapy. The encouraging research has been carried out by a small group of researchers, largely working in the United States health care context. The samples studied have been young people attending university counselling services, suffering from mild mental health disorders. The group studies are therefore not similar to patients seen for psychological therapy in the NHS. Also given that therapists are not necessarily alert to treatment failure, have an overly optimistic view of their patients progress even when provided with evidence to the contrary, clinical supervision may be a more effective method through which to provide patient informed clinical outcomes than directly to therapists themselves.

We will assess if providing feedback through the supervision process is more effective than providing this information to therapists themselves in terms of improving clinical outcomes, particularly for patients who are failing to improve with routine NHS Psychological therapy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

As above

Study Type

Interventional

Enrollment (Anticipated)

470

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
      • Glasgow, United Kingdom
        • NHS Greater Glasgow and Clyde

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients

Able to give informed consent Male or female (>18 years of age) Requiring psychological treatment or therapy in routine Mental Health Services Able and competent to understand and complete CORE questionnaires

Supervisors and their therapists

Able to give written informed consent Any NHS Greater Glasgow and Clyde applied psychologist who is supervising therapists offering routine psychological therapy to patients in NHS Greater Glasgow and Clyde and whose therapists agree to take part in the study.

Exclusion Criteria:

Patients

Below the age of 18 years Inability to give written informed consent Inability to understand and complete CORE questionnaires

Supervisors and their therapists

Those supervisors and therapists who are unlikely to be able to stay in the study for its duration.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: S-Sup
Standard supervision
Experimental: MEMOS
Patient informed clinical outcomes supervision
Other: MEMOS
Patient informed clinical outcomes supervision

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Overall CORE-OM score
Change from baseline at discharge and 6 months follow-up in the primary outcome will be compared between the supervision groups using a repeated measure analysis with appropriate correlation structure, including a random effect for therapist and fixed effects for baseline overall CORE-OM score and any other appropriate demographics.

Secondary Outcome Measures

Outcome Measure
CORE 10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

NHS Greater Glasgow and Clyde

Collaborators

University of Glasgow

Investigators

  • Principal Investigator: Kate M Davidson, MA MPhil PhD, NHS Greater Glasgow and Clyde

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2012

Primary Completion (Actual)

September 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

September 24, 2012

First Submitted That Met QC Criteria

September 24, 2012

First Posted (Estimate)

September 27, 2012

Study Record Updates

Last Update Posted (Actual)

April 19, 2019

Last Update Submitted That Met QC Criteria

April 17, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • GN12CP071
  • CZH/4/708 (Other Grant/Funding Number: Chief Scientist Office)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients Referred for Routine Psychological Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe